Dermatology Marketing
Agency in India.

NMC Section 6, ASCI, and Meta Personal Attributes —
why forty per cent of first-time skin creative gets blocked.

Every dermatology creative asset a clinic ships passes through three compliance filters before it reaches a patient. Miss any one and the asset either does not run, gets an ad-account strike, or triggers an NMC ethics complaint. The dermatology category collides with all three more frequently than any other medical specialty in India.

NMC Section 6 of the Professional Conduct Regulations 2002 governs what a registered medical practitioner can say in advertising. The relevant clauses for dermatology: no direct outcome claim ("clears acne in 30 days" is prohibited), no comparative superiority naming the doctor ("best dermatologist in Delhi" is prohibited), no testimonial that names or shows a specific patient in a way that promotes the doctor, and no before-and-after imagery used as an advertising claim. The Section is enforced through State Medical Councils, and complaints from competitors are the primary trigger.

ASCI (Advertising Standards Council of India) layers on top with the CAP Code and its healthcare guidelines. ASCI is faster to move than the NMC route — a competitor complaint typically produces a ruling in six to ten weeks — and ASCI rulings force ad withdrawal across platforms. The dermatology traps: superlatives without substantiation ("India's most trusted skin clinic"), guaranteed-result language ("100 per cent pigmentation removal"), and price claims without the actual price condition disclosed ("starting Rs.499" without noting the consultation-only scope).

Meta Personal Attributes policy is the operational chokepoint most clinics do not see coming. Meta's ad review machine rejects any creative it reads as implying the viewer has a specific personal attribute — a skin condition, a hair loss pattern, an age, a body weight. "Struggling with acne? Book a consult" is a rejection. "Learn about acne treatment options" is not. In our portfolio, roughly forty per cent of first-time dermatology creative — even from clinics that have run Meta ads for years in adjacent categories — is blocked on this policy. This is where a specialist agency stops being optional. Clearing Meta review at scale requires a creative rulebook that is written into every brief, every hook, every caption and every landing page copy line before the asset gets uploaded.

The three-regulator craft is not additive — it is intersectional. A line that passes NMC can fail ASCI. A line that passes both can be blocked by Meta. The compliant dermatology creative library is smaller than the intuitive one, and building it is the work.

Eight-vertical CPQL matrix.
ICG portfolio data, rolling 12 months.

Source: ICG portfolio data, rolling 12 months (Sept 2025-Aug 2026), n=9 dermatology engagements across solo dermatologist and multi-branch chain models. Ranges vary by city, wave and creative maturity.

Compliance is where most agencies fail.

Aesthetic dermatology and clinical dermatology have different restriction profiles. ASCI notices spike in Q3/Q4 for cosmetic clinics; NMC enforces harder on medical-derma content. ICG runs both with separate compliance sub-workflows.

Compliance interpretations current as of September 2026. Enforcement bulletins tracked weekly by ICG's compliance research desk. See our editorial standards for how we source and update these.

Condition-first content architecture.
Why "book an appointment" pages lose to "understanding your condition" hubs.

The dominant pattern in Indian dermatology marketing five years ago was a homepage plus a services grid plus a "book an appointment" form. It worked because paid search was cheap and organic discovery was thin. Both are gone. AI Overview answers commercial-intent queries with education content; Meta Reels rewards content that teaches over content that sells; the ChatGPT-native researcher will not book without first landing on a page that credibly explains the condition. The consequence is that "understanding your condition" hubs now outperform "book an appointment" pages on every metric that matters — organic sessions, session duration, WhatsApp intake, consult booking and CPQL.

The condition-first architecture that consistently wins across our portfolio has four layers. Layer one is the condition hub — a single deep page for each vertical (acne, psoriasis, vitiligo, eczema, alopecia, fungal, pigmentation, rosacea) that treats the reader as an adult trying to understand what is happening to them, not as a lead to be captured. Layer two is a set of condition-specific spokes — differential-diagnosis content, treatment-option content, cost-band content, recovery-and-follow-up content — that rank on long-tail queries and refer back to the hub. Layer three is the city-and-vertical page — the acne page for Delhi, the vitiligo page for Chennai — that carries locality-specific trust signals (branch list, empanelments, local-language elements). Layer four is the operator-guide long-form (the "how a clinic scales" and "cost benchmarks" pages) that captures the founder-doctor researcher deciding whether to hire an agency.

The compliance overlay across every layer is the same. Every condition hub, every spoke, every city page carries a named-author byline with credentials and photograph, an FAQPage schema block, an Article schema block with dateModified, an evidence citation or two where a specific claim is made, and a WhatsApp CTA that sits after the education not before it.

The Wave-1 (solo doctor) to Wave-2 (chain) growth path.
The three decisions that determine whether the chain compounds or dilutes.

The transition from Wave 1 to Wave 2 is where most dermatology practices lose their marketing engine. The founder-doctor who compounded a solo clinic to 20 patients a day suddenly cannot compound the same model across four branches with associate dermatologists. Three decisions determine whether the chain compounds or dilutes brand equity.

Decision one — brand versus branch topology. A brand-level primary site with programmatic branch pages consolidates search equity and scales content authority; separate branch sites fragment equity and require rewriting content per branch. The compounding chains we have worked with pick the brand-level model early — every new branch is a programmatic page, not a new domain. The chains that fragment usually did it because a partner acquisition brought an existing site along and nobody made the migration call.

Decision two — associate dermatologist creative governance. Associate dermatologists want to build personal brands. Chains that let five associates each run their own Instagram end up with five under-nourished handles and a diluted brand voice. The pattern that works is one brand-level handle producing brand-voice content plus surgeon-authority Reels featuring individual associates who are named and credited but not brand-primary. The associate builds authority; the brand keeps compound.

Decision three — retention SOP transfer. The founder-doctor's retention discipline in Wave 1 was informal — the founder remembered the patient. In Wave 2 that memory has to become a CRM, a WhatsApp automation, a follow-up SOP that every branch executes identically. Chains that make this transfer explicit in the first six months of the second branch's operation compound. Chains that do not lose 30 to 50 per cent of the LTV they earned in Wave 1.

90-day activation timeline
and 12-month editorial calendar.

A well-scoped medical dermatology marketing engagement moves in three 30-day sprints and settles into a rhythm by month four.

Day 0 to Day 30 — Foundation. Audit the practice's current digital footprint: GBP health score, existing website content depth, current Meta and Google Ads structure if any, review counts, and current CPQL by vertical. Build the compliance rulebook (NMC + ASCI + Meta Personal Attributes) with the founder-doctor's sign-off. Publish the priority condition hub — usually acne for a Wave-1 practice, psoriasis or vitiligo for a chronic-care-heavy practice. Claim and optimise all GBP profiles. Wire WhatsApp intake to a shared inbox. Launch the review-generation SOP.

Day 30 to Day 60 — Optimisation. First Meta creative batch clears review at the target volume (10 to 15 creative variants per week for a Wave-1 acne-primary practice). Google Ads shifts to target CPA if conversion volume clears the 30-in-30 threshold; otherwise refine keyword lists while staying on manual CPC. Publish two more condition hubs on the vertical mix priority list. Set up refill-window WhatsApp automation for the chronic verticals.

Day 60 to Day 90 — Scale. Meta Reels cadence lands at target (four to six per week for acne-primary, two to three per week for chronic-heavy). Google Ads expanded to phrase-match research layer. First long-form YouTube for vitiligo, psoriasis or eczema goes live. Review count on trajectory (60-plus new reviews in the quarter for a mid-size clinic). CPQL trending into the target range across the two or three priority verticals.

Month 4 to Month 12 — Editorial calendar. A rolling 12-month plan built around the specific vertical mix. For a Wave-1 dermatology-founder practice with acne, pigmentation, fungal and eczema services, a working monthly cadence: two condition-hub deep updates per month (rotating verticals), four to six Meta Reels per week (rotating hooks, avoiding Personal Attributes triggers), one monthly YouTube long-form on the chronic vertical mix, monthly refresh of the seasonal creative (winter psoriasis/eczema, monsoon fungal/pigmentation, post-festival pigmentation), and a quarterly review of GBP performance, ranking on priority queries, and retention SOP execution.

Eight platforms. One intelligence layer.

Nexus CRM healthcare lead management · Beacon attribution · Hawk CRM intelligence · Phoenix clinic revenue · HealthPro 360 PMS · YODA YouTube intelligence · Agency OS live reporting · AIO Intel AEO+LLM citation tracking. Built in-house since 2018 — included in every dermatology marketing agency india engagement.

Most healthcare marketing agencies treat symptoms.
ICG diagnoses root causes.

High CPL. Junk leads. Low ROAS. These are symptoms, not problems. ICG's diagnostic framework — built across 150+ healthcare engagements — maps every symptom to its actual root cause and the specific treatment that fixes it.

Every framework in this table is proprietary to ICG. Calibrated across 150+ live healthcare accounts since 2018. Full ICG methodology → · Glossary →

Anonymised engagement outcomes
from ICG dermatology portfolio.